Nuclear receptor 4A1 as a drug target for breast cancer chemotherapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nuclear receptor 4A1 as a drug target for breast cancer chemotherapy
Authors
Keywords
-
Journal
ENDOCRINE-RELATED CANCER
Volume 22, Issue 5, Pages 831-840
Publisher
Bioscientifica
Online
2015-09-02
DOI
10.1530/erc-15-0063
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma
- (2015) Erik Hedrick et al. PLoS One
- Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer
- (2014) Eva Maria Ciruelos Gil CANCER TREATMENT REVIEWS
- The Orphan Nuclear Receptor NR4A1 (Nur77) Regulates Oxidative and Endoplasmic Reticulum Stress in Pancreatic Cancer Cells
- (2014) Syng-Ook Lee et al. MOLECULAR CANCER RESEARCH
- Diindolylmethane Analogs Bind NR4A1 and Are NR4A1 Antagonists in Colon Cancer Cells
- (2014) Syng-Ook Lee et al. MOLECULAR ENDOCRINOLOGY
- Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-β signalling
- (2014) FangFang Zhou et al. Nature Communications
- Investigating a pathogenic role for TXNDC5 in tumors
- (2013) XIAOTIAN CHANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Research Resource: Nuclear Receptors as Transcriptome: Discriminant and Prognostic Value in Breast Cancer
- (2013) George E. O. Muscat et al. MOLECULAR ENDOCRINOLOGY
- Orphan nuclear receptor TR3 acts in autophagic cell death via mitochondrial signaling pathway
- (2013) Wei-jia Wang et al. Nature Chemical Biology
- The orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPK
- (2012) Yan-yan Zhan et al. Nature Chemical Biology
- Targeting NR4A1 (TR3) in cancer cells and tumors
- (2011) Syng-Ook Lee et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53
- (2011) S-O Lee et al. ONCOGENE
- Inactivation of the Orphan Nuclear Receptor TR3/Nur77 Inhibits Pancreatic Cancer Cell and Tumor Growth
- (2010) S.-O. Lee et al. CANCER RESEARCH
- A Unique Pharmacophore for Activation of the Nuclear Orphan Receptor Nur77 In vivo and In vitro
- (2010) Jing-jing Liu et al. CANCER RESEARCH
- Regulation of Nur77 expression by β-catenin and its mitogenic effect in colon cancer cells
- (2010) Hua Wu et al. FASEB JOURNAL
- Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis
- (2010) Si-Guang Xu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Minireview: Nuclear Hormone Receptor 4A Signaling: Implications for Metabolic Disease
- (2010) Michael A. Pearen et al. MOLECULAR ENDOCRINOLOGY
- Paclitaxel Directly Binds to Bcl-2 and Functionally Mimics Activity of Nur77
- (2009) C. Ferlini et al. CANCER RESEARCH
- p21 Expression Is Induced by Activation of Nuclear Nerve Growth Factor-Induced B (Nur77) in Pancreatic Cancer Cells
- (2009) S.-O. Lee et al. MOLECULAR CANCER RESEARCH
- Activation of Nerve Growth Factor-Induced B by Methylene-Substituted Diindolylmethanes in Bladder Cancer Cells Induces Apoptosis and Inhibits Tumor Growth
- (2009) S. Dae Cho et al. MOLECULAR PHARMACOLOGY
- A Short Nur77-Derived Peptide Converts Bcl-2 from a Protector to a Killer
- (2008) Siva Kumar Kolluri et al. CANCER CELL
- Cytosporone B is an agonist for nuclear orphan receptor Nur77
- (2008) Yanyan Zhan et al. Nature Chemical Biology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search